Our previous study demonstrated that TNFα + IFNγ treatment reduced FLG expression in human keratinocytes and skin lesions of mouse models with 2,4-dinitrochlorobenzene (DNCB)-induced AD-like and imiquimod-induced psoriasis-like symptoms [13]. Here, TNF is linked to Alzheimer disease.